Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 7/2012

01.07.2012 | Article

Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000–2009

verfasst von: H.-C. Hsiue, T.-H. Wu, T.-C. Chang, Y.-C. Hsiue, Y.-T. Huang, P.-I. Lee, P.-R. Hsueh

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

We reviewed 776 patients who were culture positive for Aspergillus species at the hospital from 2000 to 2009. The isolates were collected for species identification by oligonucleotide hybridization and sequence analysis. A total of 96 cases of proven or probable IA were identified according to published criteria. The incidence of IA has increased significantly during the study period. Aspergillus fumigatus and A. flavus (41.7% each) were equally prevalent causative species. IA due to unusual species including A. nidulans (n = 2), A. versicolor (n = 2), and A. tubingensis (n = 1) were also found. Among patients with IA, 55.2% had hematological disorder, 19.8% had underlying lung disorder, and 10.4% had autoimmune disease. The isolates species (P < 0.001) and underlying disease (P < 0.001) significantly affect the association of a positive culture with invasive disease. The overall mortality at three months was 62.5%, which remained stable throughout the study period. Multivariate analysis identified prior steroid use (P = 0.007) as a significant risk factor for death, while surgery (P = 0.030) and voriconazole (P = 0.012) had protective effects. In conclusion, autoimmune disorders and underlying pulmonary diseases should also be considered as important predisposing factors of IA. Further emphasis on surgery and voriconazole in the management of IA might be beneficial.
Literatur
1.
Zurück zum Zitat Lin SJ, Schranz J, Teutsch SM (2001) Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32:358–366PubMedCrossRef Lin SJ, Schranz J, Teutsch SM (2001) Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32:358–366PubMedCrossRef
2.
Zurück zum Zitat Marr KA, Carter RA, Boeckh M, Martin P, Corey L (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100:4358–4366PubMedCrossRef Marr KA, Carter RA, Boeckh M, Martin P, Corey L (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100:4358–4366PubMedCrossRef
3.
Zurück zum Zitat Rubio PM, Sevilla J, González-Vicent M, Lassaletta A, Cuenca-Estrella M, Díaz MA et al (2009) Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study. J Pediatr Hematol Oncol 31:642–646PubMedCrossRef Rubio PM, Sevilla J, González-Vicent M, Lassaletta A, Cuenca-Estrella M, Díaz MA et al (2009) Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study. J Pediatr Hematol Oncol 31:642–646PubMedCrossRef
4.
Zurück zum Zitat Guinea J, Torres-Narbona M, Gijón P, Muñoz P, Pozo F, Peláez T et al (2010) Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microb Infect 16:870–877 Guinea J, Torres-Narbona M, Gijón P, Muñoz P, Pozo F, Peláez T et al (2010) Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microb Infect 16:870–877
5.
Zurück zum Zitat Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J et al (2009) Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 48:265–273PubMedCrossRef Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J et al (2009) Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 48:265–273PubMedCrossRef
6.
Zurück zum Zitat Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Amé S, Fohrer C et al (2008) Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 47:1176–1184PubMedCrossRef Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Amé S, Fohrer C et al (2008) Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 47:1176–1184PubMedCrossRef
7.
Zurück zum Zitat Nosari A, Oreste P, Cairoli R, Montillo M, Carrafiello G, Astolfi A et al (2001) Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion. Am J Hematol 68:231–236PubMedCrossRef Nosari A, Oreste P, Cairoli R, Montillo M, Carrafiello G, Astolfi A et al (2001) Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion. Am J Hematol 68:231–236PubMedCrossRef
8.
Zurück zum Zitat Perfect JR, Cox GM, Lee JY, Kauffman CA, de Repentigny L, Chapman SW et al (2001) The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 33:1824–1833PubMedCrossRef Perfect JR, Cox GM, Lee JY, Kauffman CA, de Repentigny L, Chapman SW et al (2001) The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 33:1824–1833PubMedCrossRef
9.
Zurück zum Zitat Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA (2007) Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 44:531–540PubMedCrossRef Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA (2007) Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 44:531–540PubMedCrossRef
10.
Zurück zum Zitat De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821PubMedCrossRef De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821PubMedCrossRef
11.
Zurück zum Zitat Bulpa P, Dive A, Sibille Y (2007) Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 30:782–800PubMedCrossRef Bulpa P, Dive A, Sibille Y (2007) Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 30:782–800PubMedCrossRef
12.
Zurück zum Zitat Chen HS, Tsai WP, Leu HS, Ho HH, Liou LB (2007) Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review. Rheumatology 46:539–544PubMedCrossRef Chen HS, Tsai WP, Leu HS, Ho HH, Liou LB (2007) Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review. Rheumatology 46:539–544PubMedCrossRef
13.
Zurück zum Zitat Kim HJ, Park YJ, Kim WU, Park SH, Cho CS (2009) Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of Catholic University of Korea. Lupus 18:661–666PubMedCrossRef Kim HJ, Park YJ, Kim WU, Park SH, Cho CS (2009) Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of Catholic University of Korea. Lupus 18:661–666PubMedCrossRef
14.
Zurück zum Zitat Vandewoude KH, Blot SI, Depuydt P, Benoit D, Temmerman W, Colardyn F et al (2006) Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 10:R31PubMedCrossRef Vandewoude KH, Blot SI, Depuydt P, Benoit D, Temmerman W, Colardyn F et al (2006) Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 10:R31PubMedCrossRef
15.
Zurück zum Zitat Neofytos D, Fishman JA, Horn D, Anaissie E, Chang CH, Olyaei A et al (2010) Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis 12:220–229PubMedCrossRef Neofytos D, Fishman JA, Horn D, Anaissie E, Chang CH, Olyaei A et al (2010) Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis 12:220–229PubMedCrossRef
16.
Zurück zum Zitat Yeghen T, Kibbler CC, Prentice HG, Berger LA, Wallesby RK, McWhinney PH et al (2000) Management of invasive pulmonary aspergillosis in hematology patients: A review of 87 consecutive cases at a single Institution. Clin Infect Dis 31:859–868PubMedCrossRef Yeghen T, Kibbler CC, Prentice HG, Berger LA, Wallesby RK, McWhinney PH et al (2000) Management of invasive pulmonary aspergillosis in hematology patients: A review of 87 consecutive cases at a single Institution. Clin Infect Dis 31:859–868PubMedCrossRef
17.
Zurück zum Zitat Leaw SN, Chang HC, Sun HF, Barton R, Bouchara JP, Chang TC (2006) Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol 44:693–699PubMedCrossRef Leaw SN, Chang HC, Sun HF, Barton R, Bouchara JP, Chang TC (2006) Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol 44:693–699PubMedCrossRef
18.
Zurück zum Zitat Lai CC, Liaw SJ, Lee LN, Hsiao CH, Yu CJ, Hsueh PR (2007) Invasive pulmonary aspergillosis: high incidence of disseminated intravascular coagulation in fatal cases. J Microbiol Immunol Infect 40:141–147PubMed Lai CC, Liaw SJ, Lee LN, Hsiao CH, Yu CJ, Hsueh PR (2007) Invasive pulmonary aspergillosis: high incidence of disseminated intravascular coagulation in fatal cases. J Microbiol Immunol Infect 40:141–147PubMed
19.
Zurück zum Zitat Krishnan S, Manavathu EK, Chandrasekar PH, Krishnan S, Manavathu EK, Chandrasekar PH (2009) Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance. Mycoses 52:206–222PubMedCrossRef Krishnan S, Manavathu EK, Chandrasekar PH, Krishnan S, Manavathu EK, Chandrasekar PH (2009) Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance. Mycoses 52:206–222PubMedCrossRef
20.
Zurück zum Zitat Steinbach WJ (2005) Pediatric aspergillosis: disease and treatment differences in children. Pediatric Infect Dis J 24:358–364CrossRef Steinbach WJ (2005) Pediatric aspergillosis: disease and treatment differences in children. Pediatric Infect Dis J 24:358–364CrossRef
21.
Zurück zum Zitat Hsueh PR, Lau YJ, Chuang YC, Wan JH, Huang WK, Shyr JM et al (2005) Antifungal susceptibilities of clinical isolates of Candida Species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Antimicrob Agents Chemother 49:512–517PubMedCrossRef Hsueh PR, Lau YJ, Chuang YC, Wan JH, Huang WK, Shyr JM et al (2005) Antifungal susceptibilities of clinical isolates of Candida Species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Antimicrob Agents Chemother 49:512–517PubMedCrossRef
22.
Zurück zum Zitat Dotis J, Roilides E (2004) Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus. Internl J Infect Dis 8:103–110CrossRef Dotis J, Roilides E (2004) Osteomyelitis due to Aspergillus spp. in patients with chronic granulomatous disease: comparison of Aspergillus nidulans and Aspergillus fumigatus. Internl J Infect Dis 8:103–110CrossRef
23.
Zurück zum Zitat Segal BH, DeCarlo ES, Kwon-Chung K, Malech HL, Gallin JI, Holland SM (1998) Aspergillus nidulans infection in chronic granulomatous disease. Medicine 77:345–354PubMedCrossRef Segal BH, DeCarlo ES, Kwon-Chung K, Malech HL, Gallin JI, Holland SM (1998) Aspergillus nidulans infection in chronic granulomatous disease. Medicine 77:345–354PubMedCrossRef
24.
Zurück zum Zitat Tong Q, Chai W, Wang Z, Kou J, Qi Z, Wang D (1990) A case of cerebral aspergillosis caused by Aspergillus nidulans. Clinical, pathologic and mycologic identifications. Chin Med J 103:518–522PubMed Tong Q, Chai W, Wang Z, Kou J, Qi Z, Wang D (1990) A case of cerebral aspergillosis caused by Aspergillus nidulans. Clinical, pathologic and mycologic identifications. Chin Med J 103:518–522PubMed
25.
Zurück zum Zitat Mizuki M, Chikuba K, Tanaka K (1994) A case of chronic necrotizing pulmonary aspergillosis due to Aspergillus nidulans. Mycopathologia 128:75–79PubMedCrossRef Mizuki M, Chikuba K, Tanaka K (1994) A case of chronic necrotizing pulmonary aspergillosis due to Aspergillus nidulans. Mycopathologia 128:75–79PubMedCrossRef
26.
Zurück zum Zitat Accensi F, Cano J, Figuera L, Abarca ML, Cabañes FJ (1999) New PCR method to differentiate species in the Aspergillus niger aggregate. FEMS Microbiol Lett 180:191–196PubMedCrossRef Accensi F, Cano J, Figuera L, Abarca ML, Cabañes FJ (1999) New PCR method to differentiate species in the Aspergillus niger aggregate. FEMS Microbiol Lett 180:191–196PubMedCrossRef
27.
Zurück zum Zitat Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD et al (2009) Molecular identification of Aspergillus species: Transplant Associated Infection Surveillance Network (TRANSNET). J Clin Microbiol 47:3138–3141PubMedCrossRef Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD et al (2009) Molecular identification of Aspergillus species: Transplant Associated Infection Surveillance Network (TRANSNET). J Clin Microbiol 47:3138–3141PubMedCrossRef
28.
Zurück zum Zitat Maertens J, Buvé K, Theunissen K, Meersseman W, Verbeken E, Verhoef G et al (2009) Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer 115:355–362PubMedCrossRef Maertens J, Buvé K, Theunissen K, Meersseman W, Verbeken E, Verhoef G et al (2009) Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer 115:355–362PubMedCrossRef
29.
Zurück zum Zitat Miceli MH, Grazziutti ML, Woods G, Zhao W, Kocoglu MH, Barlogie B et al (2008) Strong correlation between serum Aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications. Clin Infect Dis 46:1412–1422PubMedCrossRef Miceli MH, Grazziutti ML, Woods G, Zhao W, Kocoglu MH, Barlogie B et al (2008) Strong correlation between serum Aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications. Clin Infect Dis 46:1412–1422PubMedCrossRef
30.
Zurück zum Zitat Ali R, Ozkalemkas F, Ozcelik T, Ozkocaman V, Ozkan A, Bayram S et al (2006) Invasive pulmonary aspergillosis: role of early diagnosis and surgical treatment in patients with acute leukemia. Ann Clin Microbiol Antimicrob 5:17PubMedCrossRef Ali R, Ozkalemkas F, Ozcelik T, Ozkocaman V, Ozkan A, Bayram S et al (2006) Invasive pulmonary aspergillosis: role of early diagnosis and surgical treatment in patients with acute leukemia. Ann Clin Microbiol Antimicrob 5:17PubMedCrossRef
Metadaten
Titel
Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000–2009
verfasst von
H.-C. Hsiue
T.-H. Wu
T.-C. Chang
Y.-C. Hsiue
Y.-T. Huang
P.-I. Lee
P.-R. Hsueh
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1445-1

Weitere Artikel der Ausgabe 7/2012

European Journal of Clinical Microbiology & Infectious Diseases 7/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.